| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ibrahim Guner, Gulderen Sahin, Nermin Karaturan Yelmen, Ugur Aksu, Tulin Oruc, Zeynep Yildiri. Intracerebroventricular serotonin reduces the degree of acute hypoxic ventilatory depression in peripherally chemodenervated rabbits. The Chinese journal of physiology. vol 51. issue 3. 2008-11-25. PMID:18935908. |
in the present study, we aimed to examine the role of central 5-ht on normoxic and acute hypoxic ventilatory depression (ahvd) in peripheral chemoreceptors denervated rabbits. |
2008-11-25 |
2023-08-12 |
Not clear |
| Albert Sattin, Albert E Pekary, James Bloo. Escitalopram regulates expression of TRH and TRH-like peptides in rat brain and peripheral tissues. Neuroendocrinology. vol 88. issue 2. 2008-11-24. PMID:18354249. |
escitalopram (ecit) is a highly selective serotonin reuptake inhibitor (ssri) that can be an effective treatment for a number of neuropsychiatric disorders including major depression. |
2008-11-24 |
2023-08-12 |
rat |
| Ronnachai Kongsakon, Chanchai Bunchapattanasakd. The treatment of major depressive disorders (MDD) in Thailand using escitalopram compared to fluoxetine and venlafaxine: a pharmacoeconomic evaluation. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. vol 91. issue 7. 2008-11-18. PMID:18839855. |
a decision analytical model was used to compare expected health outcomes and costs of treating patients with major depression using new selective serotonin reuptake inhibitor (ssri) escitalopram versus the other ssri fluoxetine and the serotonin norepinephrine reuptake inhibitor (snri) venlafaxine. |
2008-11-18 |
2023-08-12 |
Not clear |
| Brian J Mickey, Francesca Ducci, Colin A Hodgkinson, Scott A Langenecker, David Goldman, Jon-Kar Zubiet. Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 28. issue 44. 2008-11-18. PMID:18971477. |
depression diagnosis was not associated with mao-a genotype or 5-ht(1a) receptor availability in these regions. |
2008-11-18 |
2023-08-12 |
human |
| Ruth Kohen, Kevin C Cain, Pamela H Mitchell, Kyra Becker, Ann Buzaitis, Steven P Millard, Grace P Navaja, Linda Teri, David Tirschwell, Richard Veit. Association of serotonin transporter gene polymorphisms with poststroke depression. Archives of general psychiatry. vol 65. issue 11. 2008-11-18. PMID:18981341. |
association of serotonin transporter gene polymorphisms with poststroke depression. |
2008-11-18 |
2023-08-12 |
Not clear |
| Thomas Frodl, Peter Zill, Thomas Baghai, Cornelius Schüle, Rainer Rupprecht, Thomas Zetzsche, Brigitta Bondy, Maximilian Reiser, Hans-Jürgen Möller, Eva M Meisenzah. Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 147B. issue 7. 2008-11-17. PMID:18286634. |
reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. |
2008-11-17 |
2023-08-12 |
Not clear |
| Thomas Frodl, Peter Zill, Thomas Baghai, Cornelius Schüle, Rainer Rupprecht, Thomas Zetzsche, Brigitta Bondy, Maximilian Reiser, Hans-Jürgen Möller, Eva M Meisenzah. Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 147B. issue 7. 2008-11-17. PMID:18286634. |
substantial evidence supports a role for dysfunction of the serotonin transporter (5-htt) in the pathogenesis of major depression. |
2008-11-17 |
2023-08-12 |
Not clear |
| Thomas Frodl, Peter Zill, Thomas Baghai, Cornelius Schüle, Rainer Rupprecht, Thomas Zetzsche, Brigitta Bondy, Maximilian Reiser, Hans-Jürgen Möller, Eva M Meisenzah. Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 147B. issue 7. 2008-11-17. PMID:18286634. |
the polymorphism of the serotonin transporter gene (5-httlpr) was found to be associated with reduced hippocampal volume in major depression. |
2008-11-17 |
2023-08-12 |
Not clear |
| Florance Chan, Krista L Lanctôt, Anthony Feinstein, Nathan Herrmann, John Strauss, Tricia Sicard, James L Kennedy, Scott McCullagh, Mark J Rapopor. The serotonin transporter polymorphisms and major depression following traumatic brain injury. Brain injury. vol 22. issue 6. 2008-11-10. PMID:18465388. |
the serotonin transporter polymorphisms and major depression following traumatic brain injury. |
2008-11-10 |
2023-08-12 |
Not clear |
| Florance Chan, Krista L Lanctôt, Anthony Feinstein, Nathan Herrmann, John Strauss, Tricia Sicard, James L Kennedy, Scott McCullagh, Mark J Rapopor. The serotonin transporter polymorphisms and major depression following traumatic brain injury. Brain injury. vol 22. issue 6. 2008-11-10. PMID:18465388. |
the purpose of this study was to examine the role of the serotonin transporter gene polymorphisms on the risk of major depression following traumatic brain injury (tbi). |
2008-11-10 |
2023-08-12 |
Not clear |
| Chibuzo Ukaegbu, J Burton Banks, Nakia J Carter, Larry S Goldma. Clinical inquiries: what drugs are best for bipolar depression? The Journal of family practice. vol 57. issue 9. 2008-11-06. PMID:18786334. |
antidepressants, including tricyclics and selective serotonin reuptake inhibitors (ssris), are useful adjuncts in short-term treatment of bipolar depression and have low rates of inducing mania (strength of recommendation [sor]: 1 systematic review and randomized controlled trials [rcts]). |
2008-11-06 |
2023-08-12 |
Not clear |
| Hymie Anisman, Zul Merali, John D H Stea. Experiential and genetic contributions to depressive- and anxiety-like disorders: clinical and experimental studies. Neuroscience and biobehavioral reviews. vol 32. issue 6. 2008-11-05. PMID:18423590. |
indeed, animal studies have shown that vulnerability to depressive-like behaviors involve mechanisms similar to those associated with human depression (e.g., altered serotonin, corticotropin releasing hormone and their receptors, growth factors), and that the effects of stressors are influenced by previous stressor experiences, particularly those encountered early in life. |
2008-11-05 |
2023-08-12 |
human |
| Moshe Rav-Acha, Hagai Bergman, Yosef Yaro. Pre- and postsynaptic serotoninergic excitation of globus pallidus neurons. Journal of neurophysiology. vol 100. issue 2. 2008-11-05. PMID:18550726. |
furthermore, serotonin decreases the fast synaptic depression characteristic of the striatal afferent input. |
2008-11-05 |
2023-08-12 |
rat |
| Sun Hee Cho Lee, Karen Taylor, Franklin B Krasn. Reciprocal stimulation of decay between serotonergic facilitation and depression of synaptic transmission. Journal of neurophysiology. vol 100. issue 2. 2008-11-05. PMID:18562553. |
however, we unexpectedly found that pka activity is essential for the decay of depression when serotonin is washed out. |
2008-11-05 |
2023-08-12 |
Not clear |
| Janet K Brewe. Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'. Journal of molecular neuroscience : MN. vol 35. issue 3. 2008-10-30. PMID:18563304. |
however, molecular biologists have recognized that dysregulation of the ras proto-oncogene results in impaired serotonin and dopamine synthesis manifesting as major depression. |
2008-10-30 |
2023-08-12 |
Not clear |
| Lee A Dawson, Steve M Bromidg. 5-HT1 receptor augmentation strategies as enhanced efficacy: therapeutics for psychiatric disorders. Current topics in medicinal chemistry. vol 8. issue 12. 2008-10-27. PMID:18691129. |
however, it is the role of 5-ht in the pathogenesis of anxiety disorders and depression and the mechanism of action of antidepressants which has received the most attention. |
2008-10-27 |
2023-08-12 |
Not clear |
| H G Kumperscak, V Dolzan, A Videtic, B K Plesnica. Polymorphisms in genes encoding the serotonin and dopamine pathways in two sisters with metachromatic leukodystrophy. The Journal of international medical research. vol 36. issue 5. 2008-10-27. PMID:18831910. |
association studies have indicated that polymorphisms in genes encoding the serotonin and dopamine transporters and receptors are related to the symptomatology of schizophrenia and/or depression; hence both sisters were genotyped for some of these candidate genes. |
2008-10-27 |
2023-08-12 |
Not clear |
| Kentaro Murakami, Yoshihiro Miyake, Satoshi Sasaki, Keiko Tanaka, Tetsuji Yokoyama, Yukihiro Ohya, Wakaba Fukushima, Chikako Kiyohara, Yoshio Hirot. Dietary glycemic index and load and the risk of postpartum depression in Japan: the Osaka Maternal and Child Health Study. Journal of affective disorders. vol 110. issue 1-2. 2008-10-24. PMID:18192024. |
given suggestions that postpartum depression may be due to the sudden fall in insulin levels occurring after delivery via a decrease in serotonergic function, this condition might be alleviated by a high-glycemic index (gi) diet, which would stimulate the secretion of insulin and thereby facilitate the transport of tryptophan, the precursor of serotonin, in the brain. |
2008-10-24 |
2023-08-12 |
Not clear |
| Soili M Lehto, Tommi Tolmunen, Jyrki Kuikka, Minna Valkonen-Korhonen, Mikko Joensuu, Pirjo I Saarinen, Ritva Vanninen, Pasi Ahola, Jari Tiihonen, Johannes Lehtone. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study. Neuroscience letters. vol 441. issue 3. 2008-10-20. PMID:18588943. |
midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study. |
2008-10-20 |
2023-08-12 |
Not clear |
| R H Belmake. The future of depression psychopharmacology. CNS spectrums. vol 13. issue 8. 2008-10-16. PMID:18704023. |
along with the development of selective serotonin reuptake inhibitors there has been a tremendous widening of the definition of depression and an impressive decrease in the placebo-drug difference in controlled studies. |
2008-10-16 |
2023-08-12 |
human |